LAMONT DAVIS: Open Payments
NPI 1215271481 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 37 payments from 10 companies in 2025. Trend: 2023 $813 · 2024 $900 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $255 |
| Medtronic, Inc. | 4 | $198 |
| Merck Sharp & Dohme LLC | 6 | $127 |
| ABIOMED | 1 | $101 |
| PFIZER INC. | 3 | $60 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $37 |
| CVRx, Inc. | 2 | $35 |
| Amgen Inc. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
Products named: LEQVIO, AFFERA MAPPING SYSTEM, VERQUVO, ELIQUIS, PULSESELECT, LifeVest, Barostim Neo System, REPATHA.
Industry payments across TX — which companies pay providers there.
